Prime Medicine, Inc. (PRME) Free cash flow 2020–2025
Prime Medicine, Inc. (PRME) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$167.1MFY2025 · since FY2020: -$6.2M → -$167.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$167.1M | -28.4% |
| FY2024 | -$130.2M | +25.3% |
| FY2023 | -$174.1M | -17.7% |
| FY2022 | -$147.9M | -286.9% |
| FY2021 | -$38.2M | -518.3% |
| FY2020 | -$6.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice